ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 1006

$539K Total Retail Price of All Prescriptions

Rank: 200 out of 1006

466 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 8,152 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 485 467 1 2
SIMVASTATIN 412 386 2 1
AMLODIPINE BESYLATE 336 336 3 4
HYDROCHLOROTHIAZIDE 330 319 4 11
METFORMIN HCL 317 292 5 10
ATORVASTATIN CALCIUM 289 284 6 5
METOPROLOL SUCCINATE 255 240 7 12
LISINOPRIL 252 240 8 3
ZOLPIDEM TARTRATE 233 233 9 14
FUROSEMIDE 190 190 10 6
LOVASTATIN 176 174 11 44
ATENOLOL 168 164 12 13
METOPROLOL TARTRATE 163 154 13 7
DIOVAN 160 150 14 16
SERTRALINE HCL 148 140 15 19
PRAVASTATIN SODIUM 136 122 16 15
ALENDRONATE SODIUM 135 135 17 29
LOSARTAN POTASSIUM 117 117 18 22
CRESTOR 106 106 19 18
GABAPENTIN 94 83 20 20
FLUTICASONE PROPIONATE 93 93 21 55
NEXIUM 91 80 22 28
POTASSIUM CHLORIDE 87 87 23 30
DIOVAN HCT 81 79 24 60
FINASTERIDE 79 78 25 76
HYDROCODONE-ACETAMINOPHEN 79 76 S3 25 25
OMEPRAZOLE 77 59 27 9
ALLOPURINOL 65 65 28 31
ADVAIR DISKUS 64 63 29 37
LIPITOR 64 64 29 47
ENALAPRIL MALEATE 63 59 31 83
SYNTHROID 62 62 32 42
DONEPEZIL HCL 61 61 33 17
WARFARIN SODIUM 56 56 34 8
CELEBREX 55 53 35 90
QUINAPRIL HCL 52 51 36 86
KLOR-CON M20 50 50 37 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.